Product Program year 2019 Source: CMS Open Payments

Prostate Cancer - Disease

Drug

Open in the dashboard

General payments

$4,411

257 payments

Research payments

$0

0 payments

Through program year 2019, $4,411 in general payments and $0 in research payments were reported against Prostate Cancer - Disease.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $4,411 257

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $4,411 257 payments
Top recipients General payments · program year 2019
  1. Richard Conklin Hematology & Oncology · Aberdeen, SD $101 2% · 1 payment
  2. Maury Berger Medical Oncology · Ocala, FL $60 1% · 3 payments
  3. Sandeep Thaper Medical Oncology · Leesburg, FL $41 <1% · 2 payments
  4. Anju Vasudevan Medical Oncology · Ocala, FL $40 <1% · 2 payments
  5. Samuel Myrick Internal Medicine · Ocala, FL $40 <1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $1,853 43% · 94 practitioners
  2. Medical Oncology Internal Medicine $827 19% · 37 practitioners
  3. Urology $812 19% · 46 practitioners
  4. Radiation Oncology Radiology $287 7% · 17 practitioners
  5. Hematology Internal Medicine $89 2% · 5 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Florida $1,005 23% · 43 recipients
  2. Texas $721 16% · 34 recipients
  3. Ohio $688 16% · 39 recipients
  4. Michigan $458 10% · 31 recipients
  5. New Mexico $289 7% · 16 recipients

The top 5 of 25 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

257 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record